Tyra Biosciences, Inc. 8-K

What Happened
Tyra Biosciences announced in an 8-K that on April 1, 2026 the board designated Julia Rueb as the company’s principal accounting officer, succeeding Alan Fuhrman in that specific role. Mr. Fuhrman remains the company’s principal financial officer and continues as Chief Financial Officer.

Key Details

• Effective date: April 1, 2026.
• New principal accounting officer: Julia Rueb (age 40), Vice President, Finance since January 2024.
• Prior roles: Director/Senior Director of Accounting & Corporate Controller (Oct 2022–Dec 2023); Associate Director/Director, Technical Accounting at SOAProjects (Oct 2021–Oct 2022); Manager at van den Boom & Associates (Oct 2020–Oct 2021); Audit Manager at Ernst & Young (2013–Oct 2020).
• Qualifications: Master’s in Accounting (University of San Diego) and Certified Public Accountant. No family ties to company directors/executive officers.

Why It Matters
This is an internal accounting leadership change that affects who oversees the company’s accounting and reporting functions for SEC filings. Investors may view the appointment positively given Rueb’s accounting background and CPA credential. Importantly, the company’s principal financial officer (the CFO, Alan Fuhrman) remains in place, providing continuity in financial leadership.